(Sharecast News) - Smith & Nephew and Galliford Try both disclosed share dealings involving senior management and board associates on Friday.
At Smith & Nephew, chief corporate strategy and development officer Ajay Dhankhar purchased 18,460 American depositary shares in the medical technology group at $32.58 each, for a total consideration of roughly $602,000.
In a separate transaction, Kagama Family Investments LP, an entity linked to independent non-executive director Garheng Kong, acquired 3,000 shares at $33.98 apiece, worth just over $100,000.
Both transactions took place on 6 November on the New York Stock Exchange.
The purchases followed a steep share price decline this week after Smith & Nephew reported third-quarter revenue of $1.5bn, missing analyst estimates of $1.51bn due to weaker US knee implant sales.
Shares in the London-listed group fell nearly 9% on Thursday after the update, raising concerns about demand trends in key surgical markets despite solid growth in other product lines.
Meanwhile, Galliford Try said its chief financial officer Kris Hampson was issued 9,518 ordinary shares on 5 November under a buy-out award compensating for incentives forfeited at his previous employer.
He later sold 4,474 shares at 376.7p each to cover tax liabilities, with the shares repurchased by the company's employee benefit trust.
The dealings came as analyst sentiment around Galliford Try remained steady, with a consensus price target of about 598p according to Simply Wall St.
Galliford Try had also continued to expand its order pipeline, having recently secured positions on all seven lots of a £3bn affordable homes framework with the Hyde Group.
The five-year programme would deliver about 1,500 homes annually across London, the South and East of England - a move chief executive Bill Hocking said aligned with the company's Sustainable Growth Strategy to 2030.
Reporting by Josh White for Sharecast.com.
Top Director Buys
Smith & Nephew (SN.)
Director name: Kong,Garheng
Amount purchased: 3,000 @ $33.98
Value: $84,053.68
Central Asia Metals (CAML)
Director name: Ferrar,Gavin
Amount purchased: 12,669 @ 157.82p
Value: £19,993.96
Avon Technologies (AVON)
Director name: Cashin,Rich
Amount purchased: 8 @ 1,904.00p
Value: £152.32
Avon Technologies (AVON)
Director name: Sclater,Jos
Amount purchased: 8 @ 1,904.00p
Value: £152.32
(ITH)
Director name: Lewis,Iain Clifford Scobbie
Amount purchased: 66 @ 228.00p
Value: £150.48
(ITH)
Director name: Friedman ,Yaniv
Amount purchased: 66 @ 228.00p
Value: £150.48
(ITH)
Director name: Vasques ,Luciano
Amount purchased: 65 @ 228.00p
Value: £148.20
Top Director Sells
Bank Of Ireland Group (cdi) (BIRG)
Director name: O'Grady,Myles
Amount sold: 5,118 @ 14.46
Value: 74,026.24
Bank Of Ireland Group (cdi) (BIRG)
Director name: Spain ,Mark
Amount sold: 3,232 @ 14.46
Value: 46,747.32
Galliford Try (GFRD)
Director name: Hampson ,Kris
Amount sold: 4,474 @ 376.70p
Value: £16,853.56